08/10/2026
Happy 1st week-iversary of Tofersen being on the PBS ๐ฅณ๐๐ and we haven't (and won't) stopped celebrating ๐๐ค
Tofersen (QALSODYยฎ), a treatment for ALS caused by a change in the SOD1 gene, is now available through the Pharmaceutical Benefits Scheme (PBS) for eligible people.
Around 2% of people with ALS have a change in the SOD1 gene. A genetic test is needed to confirm this before treatment.
Evidence shows tofersen can slow the progression of SOD1-ALS. Research into its longer-term benefits is continuing.
Talk to your neurologist or MND clinic to find out if tofersen may be suitable for you.
Learn more about tofersen, genetic testing and PBS access: https://www.mndaustralia.org.au/info/living-with-mnd/medication-for-mnd/